Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
52
CLX Quote, Financials, Valuation and Earnings
Last price:
$98.17
Seasonality move
:
5.25%
Day range:
$97.11 - $98.33
52-week range:
$96.66 - $164.41
Dividend yield:
5.01%
P/E ratio:
15.39x
P/S ratio:
1.80x
P/B ratio:
41.96x
Volume:
831.6K
Avg. volume:
2.4M
1-year change:
-39.91%
Market cap:
$12B
Revenue:
$7.1B
EPS (TTM):
$6.38
Analysts' Opinion
-
Consensus RatingThe Clorox Co. has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 13 Hold ratings, and 2 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $122.41, The Clorox Co. has an estimated upside of 24.64% from its current price of $98.21.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $103.00 representing 100% downside risk from its current price of $98.21.
Fair Value
-
According to the consensus of 17 analysts, The Clorox Co. has 24.64% upside to fair value with a price target of $122.41 per share.
CLX vs. S&P 500
-
Over the past 5 trading days, The Clorox Co. has underperformed the S&P 500 by -4.62% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
The Clorox Co. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Clorox Co. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter The Clorox Co. reported revenues of $1.4B.
Earnings Growth
-
The Clorox Co. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter The Clorox Co. reported earnings per share of $0.65.
Enterprise value:
15.1B
EV / Invested capital:
4.68x
Price / LTM sales:
1.80x
EV / EBIT:
14.81x
EV / Revenue:
2.22x
PEG ratio (5yr expected):
0.12x
EV / Free cash flow:
23.67x
Price / Operating cash flow:
19.13x
Enterprise value / EBITDA:
12.17x
Gross Profit (TTM):
$3B
Return On Assets:
14.51%
Net Income Margin (TTM):
11.86%
Return On Equity:
347.62%
Return On Invested Capital:
25.01%
Operating Margin:
8.61%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $7B | $7.5B | $6.8B | $1.8B | $1.4B | |
| Gross Profit | $2.8B | $3.3B | $3B | $808M | $594M | |
| Operating Income | $754M | $1.2B | $1B | $295M | $123M | |
| EBITDA | $995M | $1.4B | $1.2B | $349M | $179M | |
| Diluted EPS | $0.69 | $2.86 | $6.38 | $0.79 | $0.65 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.8B | $1.8B | $1.9B | $1.6B | $1.7B | |
| Total Assets | $6.3B | $6.2B | $6B | $5.5B | $5.5B | |
| Current Liabilities | $2.6B | $2B | $2.2B | $1.6B | $2.2B | |
| Total Liabilities | $5.7B | $5.7B | $5.9B | $5.3B | $5.4B | |
| Total Equity | $547M | $496M | $131M | $224M | $138M | |
| Total Debt | $3.2B | $2.8B | $2.8B | $2.8B | $2.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1B | $896M | $853M | $221M | $93M | |
| Cash From Investing | -$201M | -$63M | -$217M | $89M | -$34M | |
| Cash From Financing | -$563M | -$1B | -$746M | -$237M | -$59M | |
| Free Cash Flow | $794M | $669M | $636M | $182M | $57M | |
CLX
Sector
Market Cap
$12B
$122.6M
Price % of 52-Week High
59.74%
70.49%
Dividend Yield
5.01%
0%
Shareholder Yield
6.06%
2.3%
1-Year Price Total Return
-39.91%
-7.14%
Beta (5-Year)
0.571
0.255
Dividend yield:
5.01%
Annualized payout:
$4.88
Payout ratio:
190.68%
Growth streak:
23 years
Technicals
8-day SMA
Sell
Level
$99.31
200-day SMA
Sell
Level
$124.01
Bollinger Bands (100)
Sell
Level
105.4 - 123.58
Chaikin Money Flow
Buy
Level
352.3M
20-day SMA
Sell
Level
$102.47
Relative Strength Index (RSI14)
Sell
Level
35.57
ADX Line
Sell
Level
39.92
Williams %R
Buy
Level
-83.564
50-day SMA
Sell
Level
$106.84
MACD (12, 26)
Sell
Level
-2.45
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
201.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.7591)
Sell
CA Score
(Annual)
Level (-1.0641)
Buy
Beneish M-Score
(Annual)
Level (-2.4709)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.4723)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The Clorox Co. engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States. The Household segments consists of bags and wraps, grilling products and cat litter marketed and sold in the United States. The Lifestyle segment refers to food, natural personal care products and water-filtration products marketed and sold in the United States. The International segment covers products sold outside the United States, excluding natural personal care products. The company was founded by Edward Hughes, Charles Husband, William Hussey, Rufus Myers, and Archibald Taft on May 3, 1913 and is headquartered in Oakland, CA.
Stock Forecast FAQ
In the current month, CLX has received 2 Buy ratings 13 Hold ratings, and 2 Sell ratings. The CLX average analyst price target in the past 3 months is $122.41.
-
Where Will The Clorox Co. Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Clorox Co. share price will rise to $122.41 per share over the next 12 months.
-
What Do Analysts Say About The Clorox Co.?
Analysts are divided on their view about The Clorox Co. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Clorox Co. is a Sell and believe this share price will drop from its current level to $103.00.
-
What Is The Clorox Co.'s Price Target?
The price target for The Clorox Co. over the next 1-year time period is forecast to be $122.41 according to 17 Wall Street analysts, 2 of them rate the stock a Buy, 2 rate the stock a Sell, and 13 analysts rate the stock a Hold.
-
Is CLX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Clorox Co. is a Hold. 13 of 17 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CLX?
You can purchase shares of The Clorox Co. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Clorox Co. shares.
-
What Is The The Clorox Co. Share Price Today?
The Clorox Co. was last trading at $98.17 per share. This represents the most recent stock quote for The Clorox Co.. Yesterday, The Clorox Co. closed at $98.21 per share.
-
How To Buy The Clorox Co. Stock Online?
In order to purchase The Clorox Co. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CLX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CLX
Sector
P/E ratio
15.39x
16.77x
PEG ratio
0.12x
0.13x
P/B ratio
41.96x
1.48x
Price / LTM sales
1.80x
0.51x
Growth Metrics
CLX
Sector
Revenue growth
-18.9%
2.99%
Earnings growth
-18.1%
5%
Revenue (5-year growth)
1.12%
3.31%
Earnings forecast
$0.78
$0.32
Profitability
CLX
Sector
Profitability FY 2025
$3.2B
$260.8M
Return on invested capital
25.01%
4.37%
Return on assets
14.51%
3.07%
Return on equity
347.62%
7.5%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Feb
3
Estimated Next Earnings Date
Feb
2
Balance Sheet
CLX
Sector
Total cash
$166M
$87.3M
Short term investments
--
$32.9M
Total assets
$5.6B
$1.1B
Long term debt
$2.8B
$6.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
87
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
60
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
